The Peptide Therapeutics Foundation is a not-for-profit 501C(3), established in 2008 to promote research and development of peptide therapeutics. The Foundation and Symposium are supported by the following corporate sponsors: AstraZeneca, ChemPartner, Ferring Research Institute, Inc., Novo Nordisk, the PolyPeptide Group, Zealand Pharma, and Zydus Cadila. To read more about our corporate sponsors (click on “Foundation Sponsors” tab) and board members, click here.
The Annual Peptide Therapeutics Symposium, held every year in San Diego, California, is a unique forum which brings together world leaders from academia, the biopharmaceutical industry, CMOs, CROs, and investors interested in all aspects of peptide R&D, including drug discovery, safety and toxicology, clinical development, manufacturing, pharmaceutical development, formulation, drug delivery, and regulatory affairs. To review the program for this year and register please click here.
Peptide Therapeutic Foundation announces the recipients of the Ferring Research Institute Innovation Grants Program for 2018:
Fiona Cousins – Hudson Institute of Medical Research, Monash University
Laurent Derré – University Hospital of Lausanne (CHUV)
Marta Dueñas – Fundación para la Investigación Hospital 12 de Octubre
Tracey Edgell – Hudson Institute of Medical Research, Monash University
Pradipta Ghosh – University of California, San Diego
Emmet Hirsch – NorthShore University HealthSystem
Sarah Marshall – Monash University
Harmeet Malhi – Mayo Clinic
Hiroshi Miyamoto – University of Rochester
Meet the 2017 Recipients:
October 25-26, 2018
The Salk Institute